Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript
08:40pm, Tuesday, 11'th Feb 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Company Participants Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier -
Gilead (GILD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:31pm, Tuesday, 11'th Feb 2025
The headline numbers for Gilead (GILD) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Markets Mixed on Powell Testimony, Q4 Earnings
07:21pm, Tuesday, 11'th Feb 2025
Tuesday, February 11, 2025 Market indexes were mixed today, after seeing all the majors in the red before the opening bell. The Dow closed up +123 points, +0.28%, while the S&P 500 squeaked by +2 poin
Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates
06:12pm, Tuesday, 11'th Feb 2025
Gilead Sciences (GILD) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.72 per share a year ago.
Gilead Sciences Beats Q4 EPS Forecast
04:40pm, Tuesday, 11'th Feb 2025
Gilead Sciences (GILD 0.69%), a major player in the biotechnology sector, reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 11, that topped analysts' consensus estimates. Adjusted e
Gilead quarterly results beat estimates
04:08pm, Tuesday, 11'th Feb 2025
Gilead Sciences posted fourth-quarter results that exceeded Wall Street estimates on Tuesday as its HIV drug sales rose 16% and acquisition-related costs fell.
Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend
04:05pm, Tuesday, 11'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Dividend--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company's Board of Directors has declared an increase of 2.6% in the company's quarterly
Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results
04:02pm, Tuesday, 11'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. “Gilead delivered another
Gilead Sciences: Diversification Strategy Not Derisked Enough Yet
03:04am, Tuesday, 11'th Feb 2025
Gilead Sciences: Diversification Strategy Not Derisked Enough Yet
Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
02:46pm, Monday, 10'th Feb 2025
We focus on biotech stocks like VRTX, GILD, BIIB, ALNY and MRNA, which are scheduled to report this week.
The Zacks Analyst Blog Uber, Comcast, Gilead Sciences and Onfolio Holdings
05:05am, Monday, 10'th Feb 2025
Uber, Comcast, Gilead Sciences and Onfolio Holdings are included in this Analyst Blog.
3 Fabulous Dividend Stocks to Buy in February
02:30pm, Sunday, 09'th Feb 2025
February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three Motley Fool contributors believe they have identified fabulous dividend stocks t
These 2 Dividend Stocks Are Absolute Bargains Right Now
08:30am, Saturday, 08'th Feb 2025
Dividend stocks are great for many reasons, not least because any company that can sustain growing payouts for a long time likely has a strong underlying business. It's even better to invest in excell
Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?
02:46pm, Friday, 07'th Feb 2025
Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports fourth-quarter 2024 results.
KBRA Assigns Preliminary Ratings to Gilead 2025-1 Aviation Limited
12:56pm, Friday, 07'th Feb 2025
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to the Series A Notes and Series B Notes issued by Gilead 2025-1 Aviation Limited and Gilead Aviation (Warehouse) LLC,
